These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37831477)

  • 21. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
    Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
    BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
    Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
    PLoS Negl Trop Dis; 2012; 6(10):e1838. PubMed ID: 23071850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system.
    Rupasinghe P; Driesen M; Vereecken J; de Jong BC; Rigouts L
    Int J Mycobacteriol; 2023; 12(3):316-323. PubMed ID: 37721239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
    Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L
    J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.
    Willby M; Sikes RD; Malik S; Metchock B; Posey JE
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5427-34. PubMed ID: 26100699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Zhang YJ; Li XJ; Mi KX
    Yi Chuan; 2016 Oct; 38(10):918-927. PubMed ID: 27806933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.
    Dauendorffer JN; Guillemin I; Aubry A; Truffot-Pernot C; Sougakoff W; Jarlier V; Cambau E
    J Clin Microbiol; 2003 Mar; 41(3):1311-5. PubMed ID: 12624075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of Type II Topoisomerase Mutations to Fluoroquinolone Resistance in Enterococcus faecium from Japanese Clinical Setting.
    Urushibara N; Suzaki K; Kawaguchiya M; Aung MS; Shinagawa M; Takahashi S; Kobayashi N
    Microb Drug Resist; 2018; 24(1):1-7. PubMed ID: 28504916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
    J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
    Chaoui I; Oudghiri A; El Mzibri M
    J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure.
    Sutera V; Hoarau G; Renesto P; Caspar Y; Maurin M
    Int J Antimicrob Agents; 2017 Sep; 50(3):377-383. PubMed ID: 28689870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China.
    Long Q; Li W; Du Q; Fu Y; Liang Q; Huang H; Xie J
    Int J Antimicrob Agents; 2012 Jun; 39(6):486-9. PubMed ID: 22526012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
    Arjomandzadegan M; Titov L; Farnia P; Owlia P; Ranjbar R; Sheikholeslami F; Surkova L
    Int J Mycobacteriol; 2016 Sep; 5(3):299-305. PubMed ID: 27847014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates.
    Hu Y; Chi Y; Feng X; Yu F; Li H; Shang Y; Pan J; Pang Y
    J Mol Diagn; 2023 Jun; 25(6):342-351. PubMed ID: 37208048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of fluoroquinolone monoresistance in Mycobacterium tuberculosis.
    Lu J; Liu M; Wang Y; Pang Y; Zhao Z
    FEMS Microbiol Lett; 2014 Apr; 353(1):40-8. PubMed ID: 24822277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.
    Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
    Antimicrob Agents Chemother; 2012 Feb; 56(2):697-702. PubMed ID: 22106221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
    Kabir S; Tahir Z; Mukhtar N; Sohail M; Saqalein M; Rehman A
    BMC Pulm Med; 2020 May; 20(1):138. PubMed ID: 32393213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase.
    Kumar R; Madhumathi BS; Nagaraja V
    Antimicrob Agents Chemother; 2014; 58(4):2013-20. PubMed ID: 24419347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Bernard C; Veziris N; Brossier F; Sougakoff W; Jarlier V; Robert J; Aubry A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1519-24. PubMed ID: 25534742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.